Registro:

Referencias:

• Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., Forman, D., Global cancer statistics (2011) CA Cancer J Clin, 61, pp. 69-90
• Bickers, B., Aukim-Hastie, C., New molecular biomarkers for the prognosis and management of prostate cancer-the post PSA era (2009) Anticancer Res, 29, pp. 3289-3298
• De Marzo, A.M., Platz, E.A., Sutcliffe, S., Xu, J., Gronberg, H., Drake, C.G., Inflammation in prostate carcinogenesis (2007) Nat Rev Cancer, 7, pp. 256-269
• Debatin, K.M., Poncet, D., Kroemer, G., Chemotherapy: Targeting the mitochondrial cell death pathway (2002) Oncogene, 21, pp. 8786-8803
• Pelicano, H., Carney, D., Huang, P., ROS stress in cancer cells and therapeutic implications (2004) Drug Resist Updat, 7, pp. 97-110
• Martindale, J.L., Holbrook, N.J., Cellular response to oxidative stress: Signaling for suicide and survival (2002) J Cell Physiol, 192, pp. 1-15
• D'Autreaux, B., Toledano, M.B., ROSassignalling molecules: Mechanismsthat generate specificity in ROS homeostasis (2007) Nat Rev Mol Cell Biol, 8, pp. 813-824
• Sherr, C.J., Principles of tumor suppression (2004) Cell, 116, pp. 235-246
• Bae, I., Fan, S., Meng, Q., Rih, J.K., Kim, H.J., Kang, H.J., BRCA1 induces antioxidant gene expression and resistance to oxidative stress (2004) Cancer Res, 64, pp. 7893-7909
• De Siervi, A., De Luca, P., Byun, J.S., Di, L.J., Fufa, T., Haggerty, C.M., Transcriptional autoregulation by BRCA1 (2010) Cancer Res, 70, pp. 532-542
• De Luca, P., Vazquez, E.S., Moiola, C.P., Zalazar, F., Cotignola, J., Gueron, G., BRCA1 loss induces GADD153-mediated doxorubicin resistance in prostate cancer (2011) Mol Cancer Res, 9, pp. 1078-1090
• Moiola, C., De Luca, P., Cotignola, J., Gardner, K., Vazquez, E., De Siervi, A., Dynamic coregulatory complex containing BRCA1, E2F1 and CtIP controls ATM transcription (2012) Cell Physiol Biochem, 30, pp. 596-608
• Gueron, G., De Siervi, A., Vazquez, E., Key questionsinmetastasis: New insights in molecular pathways and therapeutic implications (2011) Curr Pharm Biotechnol, 12, pp. 1867-1880
• Ferrando, M., Gueron, G., Elguero, B., Giudice, J., Salles, A., Leskow, F.C., Heme oxygenase 1 (HO-1) challenges the angiogenic switch in prostate cancer (2011) Angiogenesis, 14, pp. 467-479
• Poss, K.D., Tonegawa, S., Reduced stress defense in heme oxygenase 1-deficient cells (1997) Proc Natl Acad Sci U S A, 94, pp. 10925-10930
• Yachie, A., Niida, Y., Wada, T., Igarashi, N., Kaneda, H., Toma, T., Oxidative stresscauses enhanced endothelial cell injury in human heme oxygenase-1 deficiency (1999) J Clin Invest, 103, pp. 129-135
• Gueron, G., De Siervi, A., Ferrando, M., Salierno, M., De Luca, P., Elguero, B., Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells (2009) Mol Cancer Res, 7, pp. 1745-1755
• Martin, D., Rojo, A.I., Salinas, M., Diaz, R., Gallardo, G., Alam, J., Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol (2004) J Biol Chem, 279, pp. 8919-8929
• De Luca, P., Moiola, C.P., Zalazar, F., Gardner, K., Vazquez, E.S., De Siervi, A., BRCA1 and p53 regulate critical prostate cancer pathways (2013) Prostate Cancer Prostatic Dis, 16, pp. 233-238
• Aprelikova, O.N., Fang, B.S., Meissner, E.G., Cotter, S., Campbell, M., Kuthiala, A., BRCA1-associated growth arrest is RB-dependent (1999) Proc Natl Acad Sci U S A, 96, pp. 11866-11871
• Elguero, B., Gueron, G., Giudice, J., Toscani, M.A., De Luca, P., Zalazar, F., Unveiling the association of STAT3 and HO-1 in prostate cancer: Role beyond heme degradation (2012) Neoplasia, 14, pp. 1043-1056
• Giudice, J., Jares-Erijman, E.A., Leskow, F.C., Endocytosis and intracellular dissociation rates of human insulin-insulin receptor complexes by quantum dots in living cells (2013) Bioconjug Chem, 24, pp. 431-442
• Giudice, J., Barcos, L.S., Guaimas, F.F., Penas-Steinhardt, A., Giordano, L., Jares-Erijman, E.A., Insulin and insulin like growth factor II endocytosis and signaling via insulin receptor B (2013) Cell Commun Signal, 11, p. 18
• Lidke, D.S., Nagy, P., Heintzmann, R., Arndt-Jovin, D.J., Post, J.N., Grecco, H.E., Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction (2004) Nat Biotechnol, 22, pp. 198-203
• Sacca, P., Meiss, R., Casas, G., Mazza, O., Calvo, J.C., Navone, N., Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer (2007) Br J Cancer, 97, pp. 1683-1689
• Wegiel, B., Gallo, D., Csizmadia, E., Harris, C., Belcher, J., Vercellotti, G.M., Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth (2013) Cancer Res, 73, pp. 7009-7021
• Klein, E.A., Casey, G., Silverman, R., Genetic susceptibility and oxidative stress in prostate cancer: Integrated model with implications for prevention (2006) Urology, 68, pp. 1145-1151
• Otterbein, L.E., Hedblom, A., Harris, C., Csizmadia, E., Gallo, D., Wegiel, B., Heme oxygenase-1 and carbon monoxide modulate DNA repair through ataxiatelangiectasia mutated (ATM) protein (2011) Proc Natl Acad Sci U S A, 108, pp. 14491-14496
• Lin, Q.S., Weis, S., Yang, G., Zhuang, T., Abate, A., Dennery, P.A., Catalytic inactive heme oxygenase-1 protein regulates its own expression in oxidative stress (2008) Free Radic Biol Med, 44, pp. 847-855
• Gao, J., Aksoy, B.A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S.O., Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal (2013) Sci Signal, 6, p. pl1
• Cerami, E., Gao, J., Dogrusoz, U., Gross, B.E., Sumer, S.O., Aksoy, B.A., The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data (2012) Cancer Discov, 2, pp. 401-404

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------